drugset / Trial / NCT04811651
Umbilical Cord-derived Mesenchymal Stem Cells for Ischemic Stroke
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a doble blind, placebo controlled clinical trial to assess safety and efficacy of intravenous administration of Umbilical cord-derived Mesenchymal Stem cells in patients with ischemic stroke within 6 months of onset.
Timeline
- Start
- 2021-03-15
- Primary completion
- 2024-07-30
- Completion
- 2024-07-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | mesenchymal stem cells | Cell therapy | 1e+08 cells | Intravenous |